Taken together, rapamycin treatment could enhance both mitochondrial protein biosynthesis and SERCA2a activation, ultimately contributing to the amelioration of heart failure in Stx12‐cKO mice (Figure 8m). This evidence concerns the gene STX12 and heart failure.